| Nine Months Results of Gland Pharma (in Rs. Cr.) |
Dec '22 |
Dec '21 |
Dec '20 |
|
| Net Sales/Income from operations |
2,831.11 |
3,297.69 |
2,575.13 |
|
| Other Operating Income |
-- |
-- |
-- |
|
| Total Income From Operations |
2,831.11 |
3,297.69 |
2,575.13 |
|
| EXPENDITURE |
|
|
|
|
| Consumption of Raw Materials |
1,278.37 |
1,443.91 |
1,306.67 |
|
| Purchase of Traded Goods |
12.44 |
16.86 |
12.07 |
|
| Increase/Decrease in Stocks |
29.78 |
103.16 |
-218.42 |
|
| Power & Fuel |
-- |
-- |
-- |
|
| Employees Cost |
299.68 |
244.32 |
233.06 |
|
| Depreciation |
109.19 |
79.22 |
73.86 |
|
| Excise Duty |
-- |
-- |
-- |
|
| Admin. And Selling Expenses |
-- |
-- |
-- |
|
| R & D Expenses |
-- |
-- |
-- |
|
| Provisions And Contingencies |
-- |
-- |
-- |
|
| Exp. Capitalised |
-- |
-- |
-- |
|
| Other Expenses |
361.45 |
327.24 |
267.19 |
|
| P/L Before Other Inc. , Int., Excpt. Items & Tax |
740.20 |
1,082.99 |
900.70 |
|
| Other Income |
201.53 |
158.71 |
87.56 |
|
| P/L Before Int., Excpt. Items & Tax |
941.73 |
1,241.69 |
988.26 |
|
| Interest |
5.23 |
3.21 |
2.39 |
|
| P/L Before Exceptional Items & Tax |
936.49 |
1,238.49 |
985.87 |
|
| Exceptional Items |
-- |
-- |
-- |
|
| P/L Before Tax |
936.49 |
1,238.49 |
985.87 |
|
| Tax |
239.87 |
312.31 |
249.31 |
|
| P/L After Tax from Ordinary Activities |
696.62 |
926.18 |
736.55 |
|
| Prior Year Adjustments |
-- |
-- |
-- |
|
| Extra Ordinary Items |
-- |
-- |
-- |
|
| Net Profit/(Loss) For the Period |
696.62 |
926.18 |
736.55 |
|
| Equity Share Capital |
16.47 |
16.43 |
16.33 |
|
| Reserves Excluding Revaluation Reserves |
-- |
-- |
-- |
|
| Equity Dividend Rate (%) |
-- |
-- |
-- |
|
| EPS Before Extra Ordinary |
|
|
|
|
| Basic EPS |
42.32 |
56.43 |
47.12 |
|
| Diluted EPS |
42.30 |
56.43 |
47.10 |
|
| EPS After Extra Ordinary |
|
|
|
|
| Basic EPS. |
42.32 |
56.43 |
47.12 |
|
| Diluted EPS. |
42.30 |
56.43 |
47.10 |
|
| Public Share Holding |
|
|
|
|
| No Of Shares (Crores) |
-- |
-- |
-- |
|
| Share Holding (%) |
-- |
-- |
-- |
|
| Promoters and Promoter Group Shareholding |
|
|
|
|
| a) Pledged/Encumbered |
|
|
|
|
| - Number of shares (Crores) |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
|
| b) Non-encumbered |
|
|
|
|
| - Number of shares (Crores) |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
|
Source : Dion Global Solutions Limited
